Citation Impact
Citing Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
2010
No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis
1995
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis
2020
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
First-line chemotherapy for NSCLC: an overview of relevant trials
2002
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma
1998
Acute kidney injury
2012 Standout
Delayed graft function in kidney transplantation
2004 Standout
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
2010
Liver fibrosis
2005 Standout
Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index
2020
Hepatocellular carcinoma
2018 Standout
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
2008
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment—Long-term Results
2016
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1
2001
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1996
Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis
1991
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
2017
Vitamin D Deficiency
2007 Standout
Hepatocellular carcinoma
2012 Standout
Lupus nephritis: Correlation of interstitial cells with glomerular function
1990
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma
1993
Hepatitis C and liver fibrosis
2003
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens
2001
Management of Hepatocellular Carcinoma *
2005 Standout
Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation
1994
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
2004
Liver Transplantation for Hepatocellular Carcinoma
2008
Mitochondrial control of cell death
2000 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Non-alcoholic fatty liver disease
2021 Standout
Diabetes Mellitus after Kidney Transplantation in the United States
2003 Standout
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Should hepatomas be treated with hepatic resection or transplantation?
1999
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
2010
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Systemic Lupus Erythematosus
2011 Standout
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups
2008
Personalized treatment of patients with very early hepatocellular carcinoma
2016
Systemic treatment of hepatocellular carcinoma: An EASL position paper
2021
Global burden of liver disease: 2023 update
2023 Standout
Hepatitis C virus genotypes and quasispecies
1999
Comparison of Liver Transplant–Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States
2015
Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation
1997
Progress towards elimination goals for viral hepatitis
2020
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Management of splenic artery aneurysms: the significance of portal and essential hypertension11No competing interests declared.
1999
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection
2001
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
1998
Infection in Solid-Organ Transplant Recipients
2007 Standout
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
1991
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
2010
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Corticosteroid withdrawal after liver transplantation
1995
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
2000
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Hepatocellular Carcinoma
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Delayed graft function: predictive factors and impact on outcome in living-related kidney transplantations
1998
Biliary complications in right lateral sector graft live donor liver transplantation
2008
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC DONORS1
1999
Hepatocellular carcinoma
2022 Standout
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome
1993
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
2015
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
2003
Protecting single-kidney allografts from long-term functional deterioration.
1998
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis
1995
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
2019
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function
2002
MELDEQ : An alternative Model for End‐Stage Liver Disease score for patients with hepatocellular carcinoma
2015
Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy
2016
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Hepatitis C and liver transplantation
2001
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals
2017
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Lower rates of receiving model for end‐stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma
2016
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Effectiveness, Safety, and Local Progression After Percutaneous Laser Ablation for Hepatocellular Carcinoma Nodules up to 4 cm Are Not Affected by Tumor Location
2012
Bone metabolism and disease in chronic kidney disease
2003
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Delayed graft function in renal transplantation
2004
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Works of L Belli being referenced
Liver resection for hepatocellular carcinoma in cirrhotic patients.
1992
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)
2021
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
1997
Common issues in the management of patients in the waiting list and after liver transplantation
2017
Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation
1996
Lamivudine treatment for acute hepatitis B after liver transplantation
1998
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model”
2015
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation
2000
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
2015
Influence of donor and recipient gender on liver transplantation outcomes in Europe
2020
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
2013
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival
1996
Biliary complications after living donor adult liver transplantation*
2006
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases
2014
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study
2001
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
2016
The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities
2018
Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
2008
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
2017
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry
2018
Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: Clinicopathological study of resection or transplantation
1989
Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma
2005
Influence of Donor and Recipient Gender on Liver Transplantation Outcomes in Europe: A Eltr Study
2016
Immunophenotyping of mononuclear cell infiltrates associated with renal disease.
1986
Impact of Direct Anti-Viral Agents on Inactivation/De-Listing of Liver Transplant Candidates Listed for Decompensated C Cirrhosis: A European Study
2016
Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial.
1994
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
1994
Liver transplantation for small HCC in cirrhosis
1992
Palliative care in end‐stage liver disease: Time to do better?
2018
Randomized study with cyclosporine in kidney transplantation
1996
Milan multicenter experience in liver transplantation for hepatocellular carcinoma.
1994
Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria
1996
The role of donor and recipient factors in initial renal graft non-function.
1988
Splenic artery aneurysms in portal hypertension.
1983
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
1995
Docetaxel (taxotere®) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer
1998
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival
1996
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
2017
Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results
2010